联系客服

301033 深市 迈普医学


首页 公告 迈普医学:2022年度财务决算报告

迈普医学:2022年度财务决算报告

公告日期:2023-04-27

迈普医学:2022年度财务决算报告 PDF查看PDF原文

          广 州迈普再生医学科技股份有限公司

                2022 年度财务决算报告

    一、2022 年度公司财务报表审计情况

    广州迈普再生医学科技股份有限公司 2022 年度财务报表,经华
 兴会计师事务所(特殊普通合伙)审计,并出具了标准无保留意见的 审计报告。

    二、关键财务指标

        项目              2022 年          2021 年        同比增减

应收账款周转率                  24.59            23.13        6.31%

存货周转率                        1.22              1.41      -13.23%

经营活动产生的现金流量  48,309,238.18    66,510,692.29      -27.37%
净额(元)

基本每股收益(元/股)            0.54              0.79      -31.65%

加权平均净资产收益率            6.08%            10.22%        -4.14%

资产总额(元)          744,919,499.58    746,784,989.66        -0.25%

归属于上市公司股东的净  602,582,289.54    572,257,657.41        5.30%
资产(元)

资产负债率                      19.11%            22.89%        -3.78%

    三、主要财务数据

    2022 年度公司实现营业收入 19,525.24 万元,较去年同期增长
 26.96%;营业利润为 4,134.71 万元,较去年同期下降 5.41%;利润 总额为 3,996.24 万元,较去年同期下降 22.55%;归属上市公司股东

  的净利润为 3,589.18 万元,较去年同期下降 19.73%;归属于上市公

  司股东的扣除非经常性损益的净利润为 2,393.80 万元,较去年同期

  增长 2.67%。

      1、2022 年度经营情况变动及说明

                                                              单位:万元

项目              2022 年        2021 年    同比增减          重大变动说明

营业收入              19,525.24    15,378.57      26.96%

营业成本              3,122.83    2,708.81      15.28%

销售费用              7,027.32    4,859.42      44.61%  主要系本报告期业务推广费增
                                                          加所致

管理费用              3,529.87    2,441.00      44.61%  主要系本报告期增加总部基地
                                                          折旧摊销及职工薪酬增加所致

研发费用              3,061.43    2,587.54      18.31%

                                                          主要系本报告期利息收入增加
财务费用                -10.01        68.24    -114.67%  及汇率变动导致汇兑损益减少
                                                          所致

公允价值变动收          -80.71        97.96    -182.39%  主要系本报告期公司购买理财
益                                                        产品公允价值变动所致

投资收益                879.23      609.70      44.21%  主要系本报告期公司购买理财
                                                          产品产生收益所致

其他收益                734.03    1,032.31      -28.89%

营业外支出              142.39        12.83    1010.24%  主要系本报告期场地退租,长
                                                          期待摊费用报废所致

  2、2022 年末资产负债表项目变动及说明

                                                              单位:万元

项目          2022 年 12 月 31 日  2021年12月31日 同比增减    重大变动说明

货币资金              4,495.71        1,035.19      334.29%  主要系本期赎回理财所
                                                                致

交易性金融资        14,706.60        37,557.15      -60.84%  主要系本报告期购买理
产                                                              财产品减少所致

应收账款              1,041.67          531.91      95.83%  主要系本报告期赊销增
                                                                加所致

                                                                主要系本报告期预付检
预付款项                461.07          268.12      71.96%  测费、临床试验费等增加
                                                                所致

其他应收款              132.66          139.89      -5.17%


项目          2022 年 12 月 31 日  2021年12月31日 同比增减    重大变动说明

存货                  2,940.99        2,117.73      38.87%  主要系本报告期备货增
                                                                加所致

其他流动资产              46.24            64.23      -28.01%

其他权益工具            210.37                -      不适用  主要系本报告期对外投
投资                                                            资所致

其他非流动金          2,800.00                -      不适用  主要系本报告期对外投
融资产                                                          资所致

投资性房地产          1,189.72                -      不适用  主要系本报告期出租自
                                                                有房产所致

固定资产              31,603.32        2,192.47    1341.45%  主要系总部基地转固,设
                                                                备购买增加所致

在建工程                  1.63        20,194.63      -99.99%  主要系总部基地转固所
                                                                致

使用权资产              376.80          758.99      -50.35%  主要系本报告期场地退
                                                                租,处置使用权资产所致

无形资产              5,131.19        5,465.92      -6.12%

                                                                主要系硬脑膜医用胶及
开发支出              3,151.05        2,155.26      46.20%  口腔可吸收修复膜项目
                                                                投入增加所致

                                                                主要系本报告期场地退
长期待摊费用            305.39          560.70      -45.53%  租,长期待摊费用报废所
                                                                致

                                                                主要系部分退租导致租
递延所得税资            93.12          424.33      -78.06%  赁负债减少、子公司本报
产                                                              告期盈利导致可弥补亏
                                                                损减少所致

其他非流动资          5,804.42        1,211.99      378.92%  主要系大额存单增加所
产                                                     
[点击查看PDF原文]